Whether in pathological conditions or at high altitude, hypoxia can severely affect survival, early development, and fitness of an organism ([@bib33]; Shimoda and [@bib45]; [@bib58]). Depending on the duration and severity of hypoxia, cell type, tissue, or organism, the injury caused by hypoxia could be significant and irreversible. Hence, it can result in long-term morbidity and mortality in humans, especially in infants ([@bib42]). To maintain function and homeostasis, cells sense and respond to inadequate oxygen levels ([@bib15]; [@bib25]; [@bib45]). Some aspects of the response involve changes in gene expression, and a number of studies have identified various sensitivities of cells and organisms to hypoxic stress ([@bib1]; [@bib10]; [@bib15]; [@bib28]; [@bib29]), including a variety of genetic pathways and mechanisms that can potentially affect the response to hypoxia.

Hypoxia-tolerant organisms, such as the African naked mole-rats, Crucian carp, aquatic turtles, and fruit flies, provide a unique opportunity to study the effect of genes influencing hypoxia tolerance or injury *in vivo* ([@bib21]; [@bib29]; [@bib37]). The added advantages of using *Drosophila* as a model system is that their genome has been sequenced, many human disease genes are conserved in *Drosophila*, and a number of genetic tools and stocks are available for manipulation of genes *in vivo*. In particular, there is a vast array of single transposon insertions covering almost the entire *Drosophila* genome ([@bib5]; [@bib49]). We have chosen to perform an unbiased screen of P-Sup P-element lines covering a large portion of the *Drosophila* genome to determine the potentially interesting genes in hypoxia tolerance.

Materials and Methods {#s1}
=====================

Fly stocks {#s2}
----------

P{SUPor-P} ([@bib43]) P-element set for chromosomes X, 2, 3, and Y were obtained from the Bloomington Drosophila Stock Center (Bloomington, Indiana, USA). A list of all the genes included in our P-element screen is attached as [supporting information](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.003681/-/DC1/003681SI.pdf), [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.003681/-/DC1/TableS2.pdf). The UAS, TRIP, and RNAi lines were obtained from the Bloomington Drosophila Stock Center and Vienna Drosophila RNAi Center (Vienna, Austria), respectively. *Osa* gene stocks were kindly provided by Dr. Jessica Treisman (NYU School of Medicine). The Gal4 drivers da, Eaat1, Elav, P{GawB}c739, P{GawB}DJ667, He, and Hml were obtained from the Bloomington Drosophila Stock Center.

P-element screening for hypoxia tolerance {#s3}
-----------------------------------------

The P-element lines were tested for hypoxia tolerance based on two phenotypes: (1) eclosion rates at 5% O~2~ and (2) adult flies that survived post eclosion at 5% O~2~.

### Eclosion rates at 5% O~2~: {#s4}

For each P-element line, 50 females and males were put in a vial with standard corn-meal food. After allowing females to lay eggs for about 6 hr (to obtain about ≥100 eggs), the vials were cleared and the eggs were put under 5% O~2~ for 4 weeks in specially designed computerized chambers (Model A44x0, BioSpherix, Redfield, NY) and ANA-Win2 Software (Version 2.4.17, Watlow Anafaze, CA). After 4 weeks, the number of eclosed and un-eclosed pupae was counted, and the percentage eclosion was calculated for each P-element line tested. Percentage eclosion was determined by calculating the ratio of the number of empty pupae to the total number of pupae in each culture vial. In our screen, we maintained a minimum pupariation of 50% to ensure that the percentage eclosion rate was not biased based on pupae number. We and others have shown that in the *Drosophila* life cycle, the pupal stage is a critical oxygen-sensitive stage, and hence, we chose this phenotype for our screen ([@bib19]; [@bib40]; [@bib60]). Particularly, we have observed that eclosion under hypoxia for controls is severely affected by hypoxia (eclosion rate less than 10%). The lines that showed percentage eclosion \>70% were re-tested at least three times, starting with 100--150 eggs at 5% O~2~, to confirm the results. We chose a 70% cut off since it was significantly higher than all the control fly types (7--8%) and driver fly stocks (45--50%).

### Adult flies that survived post eclosion at 5% O~2~: {#s5}

For each line (each P-element line retested as well as controls), we started with 100--150 eggs in the vial and kept them at 5% O~2~ for 4 weeks, and then counted the average number of adults that survived one week after eclosion.

Real-time PCR analysis of P-element lines {#s6}
-----------------------------------------

Total RNA was extracted from flies (yw-control and P-elements) under normoxia, using Trizol (Invitrogen, Carlsbad, CA). cDNA was produced from total RNA through RT-PCR using Superscript III First-Strand Synthesis system (Invitrogen).

Real-time PCR was performed using a GeneAmp 7500 sequence detection system using POWER SYBR Green chemistry (Applied Biosystems, Foster City, CA). The expression level of Actin was used to normalize the results (fwd: CTAACCTCGCCCTCTCCTCT; rev: GCAGCCAAGTGTGAGTGTGT). The fold change was calculated using expression level of yw in normoxia as well as hypoxia, which was used as control for all the P-element lines. P-elements with eclosion rate of greater than 85% were tested with real-time PCR. The primer information for the P-elements genes is provided in [Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.112.003681/-/DC1/TableS1.pdf).

Tissue-specific upregulation or downregulation of genes from P-element screen {#s7}
-----------------------------------------------------------------------------

Depending on the expression of genes in the P-element lines, UAS or RNAi stock of genes were used to overexpress or knockdown the expression of the genes ubiquitously or in specific tissues in the F1 progeny using various Gal4 drivers. The Gal4 drivers used were da (expresses in all tissues), Eaat1 (glial cells), elav-Gal4 \[neurons-nervous system (CNS and PNS)\], P{GawB}c739 \[strong expression in alpha and beta lobe Kenyon cells (intrinsic neurons) of the Mushroom bodies\], P{GawB}DJ667 (adult muscles), He-Gal4 (hemocytes), and Hml-Gal4 (larval hemocytes). In the F1 progeny, eclosion rates were calculated after 4 weeks under 5% O~2~ for one developmental cycle (egg-adult). Unpaired Student *t*-tests were used to calculate significant differences in the percentage eclosion of each P-element line, or F1-progeny of UAS, TRIP, or RNAi lines and Gal4 drivers compared with the controls.

Data analysis and statistical tests {#s8}
-----------------------------------

For selection of strongly hypoxia tolerant line we chose a cutoff of \>70% eclosion which was 10-fold higher than CS control eclosion rate. The gene ontology (GO)-based analyses were performed using GenMAPP software ([@bib14]). The pathway analysis of the candidate genes was done using DAVID program utilizing KEGG and PANTHER, as well as FLIGHT, databases ([@bib23]; [@bib35]; [@bib44]; [@bib48]).

Results {#s9}
=======

Genome-wide P-element screen for hypoxia tolerance genes {#s10}
--------------------------------------------------------

To identify genes involved in hypoxia tolerance, we screened P-element insertion lines generated by BDGP Gene Disruption Project ([@bib5]; [@bib43]). We specifically chose SuP or P insertion lines because these P-elements were designed to maximally disrupt genes ([@bib5]; [@bib32]; [@bib43]). Out of 2187 lines (covering ∼1870 genes) screened, 44 P-element lines (44 genes) had rather high eclosion rates (\>70% eclosion). [Table 1](#t1){ref-type="table"} and [Figure 1](#fig1){ref-type="fig"} show the eclosion rates (each line was retested starting with 100--150 eggs in each vial) and the average number of adult eclosed flies surviving under 5% O~2~ for the P-elements lines that were hypoxia-tolerant. [Table 1](#t1){ref-type="table"} also shows the human orthologs of the genes found in our screen. In this screen, we found certain interesting candidate genes, such as *[sec8](http://flybase.org/reports/FBgn0262603.html)*, *[cpa](http://flybase.org/reports/FBgn0034577.html)*, *[cyclin E](http://flybase.org/reports/FBgn0010382.html)*,*[osa](http://flybase.org/reports/FBgn0261885.html)*, *[l(3)mbn](http://flybase.org/reports/FBgn0002440.html)*, *[Alh](http://flybase.org/reports/FBgn0261238.html)*, and *[tna](http://flybase.org/reports/FBgn0026160.html)*, which show remarkable (70--80%) eclosion rates and hypoxia tolerance during all stages of the developmental cycle (egg to adult) ([Table 1](#t1){ref-type="table"} and [Figure 1](#fig1){ref-type="fig"}). The eclosion rate of the controls and P-element lines was 98--100%, in normoxia.

###### Percentage eclosion and number of adult flies surviving in controls (CS, yw) and P-element lines at 5% O~2~

  Gene Symbol   Chr   \% Eclosion    Adult Flies   \% Pupriation   Molecular Function                                                                                                 Human Orthologs
  ------------- ----- -------------- ------------- --------------- ------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------
  CS(control)         6.8 ± 0.67     1 ± 0.03      85.7 ± 5.68                                                                                                                        
  yw(control)         7.5 ± 2.15     0             81.5 ± 10.25                                                                                                                       
  CG14782       X     75 ± 10.5      10 ± 5.4      97 ± 6.7        Guanyl-nucleotide exchange factor activity                                                                         Pleckstrin homology domain containing, family F (with FYVE domain) member 2/ PLEKHF2
  CG15742       X     75 ± 13.3      4 ± 0.9       89 ± 10.12      Unknown                                                                                                            
  CG9413        X     80 ± 8.9       10 ± 5.8      78 ± 5.15       Amino acid trasmembrane transporter activity                                                                       Solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9/ SLC7A9
  Dip1          X     72 ± 9.9       8 ± 2.3       75 ± 3.22       Double-stranded RNA binding                                                                                        
  CG10700       2     84.5 ± 0.95    20 ± 2.5      78 ± 10.2       Electron carrier activity; FAD binding                                                                             
  CG2915        2     74 ± 12        21 ± 1.8      69 ± 5.67       Metallocarboxypeptidase activity; zinc ion binding                                                                 
  CG30169       2     76 ± 23        5 ± 1.2       72 ± 12.35      Unknown                                                                                                            
  CG4612        2     71 ± 0.45      22 ± 6.7      89 ± 10.42      mRNA binding; poly(A) binding; nucleotide binding                                                                  
  CG6230        2     88 ± 3.5       47 ± 10.6     82 ± 12.5       ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; ATP binding                 ATPase type 13A1/ ATP13A1
  CG6860        2     90.47 ± 5.7    23 ± 2.5      80 ± 13.45      Protein binding                                                                                                    Leucine-rich repeats and calponin homology (CH) domain containing 1/ LRCH1
  CG8677        2     82.1 ± 7.4     3 ± 0.5       73.1 ± 9.4      Transcription repressor activity; protein binding; zinc ion binding                                                Cat eye syndrome chromosome region, candidate 2/ CECR2
  cpa           2     90 ± 3.6       42 ± 9        85 ± 11.5       Actin binding                                                                                                      Capping protein (actin filament) muscle Z-line, alpha 1/ CAPZA1
  CycE          2     70.4 ± 4.8     14 ± 6.8      72 ± 4.2        Cyclin-dependent protein kinase regulator activity                                                                 
  Drp1          2     72.5 ± 7.5     12 ± 4.8      73 ± 6.77       GTP binding; GTPase activity                                                                                       Dynamin 1-like/ DNM1L
  Fak56D        2     75.19 ± 0.57   5 ± 0.99      72.0 ± 10.22    Protein tyrosine kinase activity                                                                                   PTK2 protein tyrosine kinase 2/ PTK2
  mRpS18B       2     88 ± 3.5       3 ± 1.3       76 ± 11.34      Mitochondrial ribosomal protein, structural constituent of ribosome                                                Mitochondrial ribosomal protein S18B/MRPS18B
  Mys45A        2     89 ± 6         20 ± 7.9      81 ± 12.6       Binding                                                                                                            SDA1 domain containing 1/ SDAD1
  Rep2          2     87.2 ± 2.25    39 ± 2.6      75.3 ± 10.27    Protein binding                                                                                                    
  Alh           3     76 ± 4.5       5 ± 0.77      75 ± 8.77       Transcription factor activity                                                                                      Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)/ MLLT10
  Atg1          3     88 ± 2.99      20 ± 3.6      93 ± 6.90       Protein kinase activity; protein serine/threonine kinase activity; kinesin binding; kinase activity; ATP binding   Unc-51-like kinase 2 (C. elegans)/ ULK2
  Bgb           3     87 ± 3.78      7 ± 1.3       77 ± 5.12       Positive regulation of transcription from RNA polymerase II promoter                                               Core-binding factor, beta subunit/ CBFB
  ced-6         3     73 ± 10.6      3 ± 0         83 ± 9.9        Protein binding                                                                                                    GULP, engulfment adaptor PTB domain containing 1/ GULP1
  CG14185       3     83 ± 5.66      8 ± 3.44      69 ± 14.65      Protein binding                                                                                                    
  CG17273       3     86.7 ± 20.1    10 ± 2.3      82.7 ± 6.8      Adenylosuccinate synthase activity; GTP binding                                                                    Adenylosuccinate synthase/ ADSS
  CG32064       3     84.4 ± 4.5     30 ± 2.6      80 ± 9.23       Proteolysis                                                                                                        
  CG33169       3     76.5 ± 7.99    11 ± 2.7      96.5 ± 10.55    Unknown                                                                                                            
  CG5235        3     89 ± 9.7       16 ± 5.6      77 ± 12.6       Dopamine beta-monooxygenase activity                                                                               Monooxygenase, DBH-like 1/ MOXD1
  CG6028        3     75 ± 10.89     20 ± 2.45     72 ± 9.8        GTP binding                                                                                                        Fumarylacetoacetate hydrolase domain containing 2A/ FAHD2A
  CG8116        3     89.2 ± 6.5     26 ± 12.7     92.2 ± 17.5     Unknown                                                                                                            Transmembrane protein 216/ TMEM216
  CG8177        3     79 ± 8.97      10 ± 3.33     73 ± 3.2        Anion exchanger activity; inorganic anion exchanger activity                                                       Solute carrier family 4, anion exchanger, member 3/ SLC4A3
  CG8180        3     86 ± 1.33      7 ± 2.3       78 ± 7.8        Unknown                                                                                                            
  CG9737        3     77.6 ± 8.9     9 ± 2.2       80.6 ± 4.5      Proteolysis; phagocytosis, engulfment                                                                              
  chb           3     70.8 ± 1.22    15 ± 1.2      90.2 ± 13.75    GTP binding; microtubule binding                                                                                   Cytoplasmic linker associated protein 1/ CLASP1
  Chro          3     80 ± 7.9       7 ± 2         93 ± 6.49       Chromatin binding                                                                                                  
  l(3)mbn       3     85 ± 6.79      32 ± 3.9      79 ± 8.5        Plasmatocyte differentiation                                                                                       
  lqf           3     90.3 ± 3.5     3 ± 0.22      93 ± 15.2       Regulation of Notch signaling pathway                                                                              Epsin 3/ EPN3
  Manf          3     86 ± 3.57      5 ± 2.22      92 ± 9.2        Neuron maintenance; neuron projection development                                                                  Mesencephalic astrocyte-derived neurotrophic factor/ MANF
  osa           3     86.3 ± 9.9     58 ± 10.2     98.5 ± 10.3     DNA binding; transcription coactivator activity                                                                    SWI/SNF
  polo          3     80 ± 2.35      11 ± 1        99 ± 10.34      Cell cycle; protein kinase activity                                                                                Polo-like kinase 1/ PLK1
  pzg           3     74 ± 1.5       11.5 ± 1.5    70 ± 3.67       Cell cycle; establishment or maintenance of chromatin architecture; chromosome organization                        
  Scrib         3     90 ± 2.1       18 ± 2        86 ± 10.7       Protein binding                                                                                                    
  sec8          3     85 ± 2         36 ± 6.9      77 ± 7.89       Neurotransmitter secretion                                                                                         
  tna           3     89 ± 9.86      20 ± 4.22     85 ± 12.5       Chromatin-mediated maintenance of transcription                                                                    Zinc finger, MIZ-type containing 2/ ZMIZ2
  ci            4     89 ± 6.77      5 ± 1.77      95 ± 8.95       Protein binding, cell cycle regulation                                                                             GLI family zinc finger 3/ GLI3

Also shown are human orthologs of the candidate genes.

![P-element screen for hypoxia tolerance genes. Percentage eclosion and average number of adult flies surviving of P-element lines on chromosomes 1--4 at 5% O~2~. Each bar represents the average of at least three tests for each line (starting with 100--150 eggs); error bars represent the standard error. The number of lines tested for each chromosome is shown in brackets.](1169f1){#fig1}

Functional categorization of candidate genes {#s11}
--------------------------------------------

GO and pathway analyses were performed to determine the predominant biological processes and pathways that are potentially regulated by the candidate genes and play a role in hypoxia tolerance. The biological process categories in which these candidate genes were overrepresented include spindle organization, synaptic vesicle endocytosis and transport, regulation of transcription, and cell cycle ([Figure 2A](#fig2){ref-type="fig"}). The molecular function of the mutated genes in the hypoxia-resistant P-element insertion lines ranged from transcriptional co-regulators, to DNA or protein binding, to ATP and GTP binding, to carrier activity, to metalloexopeptidase and exopeptidase activity ([Figure 2B](#fig2){ref-type="fig"} and [Table 1](#t1){ref-type="table"}). For example, we found that P-element lines of a number of transcriptional regulators, such as *[osa](http://flybase.org/reports/FBgn0261885.html)*, *[Alh](http://flybase.org/reports/FBgn0261238.html)*, and *[tna](http://flybase.org/reports/FBgn0026160.html)*, had a strong hypoxia resistance phenotype. Starting with 100--150 eggs, we observed that the downregulated osa line had a high eclosion rate (86%) and that the average number of flies that survived after eclosion are ∼58 flies (\>50%), which is significantly higher compared with controls (eclosion rate 7%, and average number of adults surviving after eclosion \<2). [Table 2](#t2){ref-type="table"} shows the pathways related to the 44 candidate genes found in our screen. It is intriguing that we find a strong link to Notch pathway (20 genes/44 genes), but at the same time, we also discovered other pathways, such Wnt, Erk, Hedgehog or JAK/ STAT, and VEGF pathways, that seem to play important roles in hypoxia tolerance.

![Overrepresented functions in the hypoxia tolerant P-element lines as computed by GO. (A) Biological processes predominant for hypoxia tolerance (egg-adult) under 5% O~2~. (B) Molecular processes predominant for hypoxia tolerance (egg-adult) under 5% O~2~.](1169f2){#fig2}

###### Signaling pathways linked to the candidate genes

  Symbol    Gene      Signaling Pathway[*^a^*](#t2n1){ref-type="table-fn"}
  --------- --------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  CG15742   CG15742   JNK modifier
  Dip1      CG15367   1\) Innate immunity 2) Notch signaling
  CG14782   CG14782   1\) JNK modifier 2) Notch signaling
  CG9413    CG9413    Not detected
  CG2915    CG2915    Not detected
  mRpS18B   CG10757   Notch signaling
  Mys45A    CG8070    1\) Lipid storage 2) Notch signaling 3) Cardiogenic genes
  CG6230    CG6230    Notch signaling
  cpa       CG10540   1\) M. fortuitum infection 2) Morphogenesis 3) Phagocytosis
  CG4612    CG4612    1\) JNK modifier 2) Mito Ca^2+^ and H+ regulation
  CycE      CG3938    1\) M. fortuitum infection 2) Morphogenesis 3) Lipid storage 4) miRNA pathway 5) cell cycle 6) p53 pathway 7) Ubiquitination pathway
  Drp1      CG3210    1\) Mito morphology 2) Notch signaling 3) Ca^2+^ signaling (Ca^2+^ entry) 4) Endocytosis
  Rep2      CG1975    Notch signaling
  CG6860    CG6860    Not detected
  Fak56D    CG10023   1\) Angiogenesis 2) Integrin signaling pathway 3) VEGF signaling pathway
  CG10700   CG10700   Not detected
  CG30169   CG30169   Not detected
  CG8677    CG8677    Not detected
  osa       CG7467    1\) Wnt signaling 2) Mito Ca^2+^ and H+ regulation 3) Notch signaling
  CG32064   CG32064   1\) Glutathione metabolism 2) Sesquiterpenoid and triterpenoid biosynthesis in Urea cycle metabolism
  CG8116    CG8116    Notch signaling
  sec8      CG2095    1\) *E. coli*/*S. aureus* infection 2) Phagocytosis
  Atg1      CG10967   1\) Cell cycle kinase 2) Notch pathway 3) Regulation of authophagy 4) mTOR signaling pathway
  l(3)mbn   CG12755   ERK signaling
  CG5235    CG5235    Not detected
  CG8177    CG8177    1\) Multipolar division 2) Ca^2+^ signaling (Ca^2+^ entry inhibition)
  CG33169   CG33169   Notch signaling
  CG17273   CG17273   1\) Innate immunity 2) Purine metabolism 3) Alanine-aspartate and glutamate metabolism 4) Wnt signaling pathway 5) De novo purine biosynthesis 6) Metabolic pathways
  CG9737    CG9737    Phagocytosis
  Chro      CG10712   1\) M. fortuitum infection 2) Hedgehog signaling 3) Notch signaling
  pzg       CG7752    1\) JAK/STAT signaling 2) ERK signaling 3) E2F signaling 4) Notch signaling 5) Hedgehog signaling 6) M. fortuitum infection 7) Ca^2+^ signaling
  ced6      CG11804   1\) *C. trachomatis* infection 2) Ca^2+^ signaling
  polo      CG12306   1\) Cell cycle kinase 2) Kinase cell progression 3) Centrosome number 4) Mitosis 5) Morphogenesis 6) Cytoskeletal morphogenesis 7) DFoxO signaling 8) Notch signaling 9) Phagocytosis 10) Apoptosis pathway 11) Progesterone-mediated oocyte maturation 12) Endocytosis
  Bgb       CG7959    Not detected
  Iqf       CG8532    1\) Insect dengue virus infection 2) Endocytosis 3) Notch signaling
  chb       CG32435   1\) ERK signaling 2) Tublin flux 3) Mitosis
  Scrib     CG42614   1\) Innate immunity 2) Cardiogenic genes 3) Notch signaling 4) Ca^2+^ signaling
  CG8180    CG8180    1\) JAK/STAT signaling 2) ERK signaling
  Alh       CG1070    1\) Cell growth and viability 2) Mito Ca^2+^ and H+ regulation 3) Notch signaling
  CG6028    CG6028    Not detected
  tna       CG7958    1\) Cell growth and viability 2) Wnt signaling 3) Notch signaling 4) Hedgehog signaling 5) Ca^2+^ signaling 6) Dpp signaling 7) Interferon-gamma signaling pathway 8) JAK/STAT signaling pathway
  CG14185   CG14185   Notch signaling
  Manf      CG7013    Not detected
  ci        CG2125    1\) Hedgehog signaling 2) Notch signaling

Signaling pathways are based on DAVID (KECK and PANTHER database) and FLIGHT database.

Overexpression or knockdown of single genes and hypoxia tolerance {#s12}
-----------------------------------------------------------------

Before we studied the role of each differentially expressed gene, we performed real-time PCR, as shown in [Figure 3](#fig3){ref-type="fig"}. PCR showed that in these P-elements, the expression of some of the genes was indeed significantly altered under normoxia and hypoxia ([Figure 3](#fig3){ref-type="fig"}). For example, *[sec8](http://flybase.org/reports/FBgn0262603.html)*, *[osa](http://flybase.org/reports/FBgn0261885.html)*, and *[tna](http://flybase.org/reports/FBgn0026160.html)* were significantly downregulated, and *[l(3)mbn](http://flybase.org/reports/FBgn0002440.html)*, *[Alh](http://flybase.org/reports/FBgn0261238.html)*, *[lqf](http://flybase.org/reports/FBgn0028582.html)*, *[CG5235](http://flybase.org/reports/FBgn0036565.html)*, *atg1*, and *[ci](http://flybase.org/reports/FBgn0004859.html)* were more than 1.5-fold upregulated. To understand the mechanisms underlying hypoxia tolerance *in vivo*, we overexpressed (using the UAS-Gal4 system) or knocked down (RNAi) these genes ubiquitously (*e.g*. da-gal4 drivers) or in specific tissues, depending on whether these particular genes were upregulated or downregulated in the P-elements ([Figure 4](#fig4){ref-type="fig"}). We chose to study in detail 4 genes (out of the 44 from our initial screen) based on the following criteria: a) they showed a strong hypoxia phenotype \[*e.g.* the *[osa](http://flybase.org/reports/FBgn0261885.html)* gene had a percentage eclosion of 86.3 ± 9.9 and had the highest average number of flies (58 ± 10.2) that survived post eclosion\]; b) they showed a clearly significant upregulation or downregulation in the P-element line by real-time PCR; and c) availability of fly lines (either UAS or RNAi) and mutants to further study their effect *in vivo*. Hence, we decided to further study the following genes: *[osa](http://flybase.org/reports/FBgn0261885.html)*, *[lqf](http://flybase.org/reports/FBgn0028582.html)*, *[tna](http://flybase.org/reports/FBgn0026160.html)*, and *[sec8](http://flybase.org/reports/FBgn0262603.html)* ([Figure 4](#fig4){ref-type="fig"}). Indeed we found that the upregulation or downregulation of these genes in these P-element lines had a functional significance under hypoxia. When we upregulated or knocked down the genes using UAS, TRIP, or RNAi lines and ubiquitous da-GAL4 driver, the resulting F1 progeny and mutant stocks matched the phenotype we observed in the P-element lines under hypoxia. For example, we found that knockdown of *[osa](http://flybase.org/reports/FBgn0261885.html)* (either by a TRIP RNAi or with a hypomorph mutant) leads to a tremendous increase of eclosion of flies in hypoxia (*P* \< 0.05; [Figure 4](#fig4){ref-type="fig"}). We also tested the artificial constructs of *[osa](http://flybase.org/reports/FBgn0261885.html)* gene in which the gene was attached to a constitutive activating or repressor domain ([@bib12]). Our results showed that constitutive repression of osa (as seen in F1-UAS-osaRDXdagal4) leads to better eclosion under hypoxia, whereas upregulation of osa (F1-UAS-osaXdagal4 or F1-UAS-osaADXdagal4) leads to significantly lower eclosion rate under hypoxia. This is consistent with the hypothesis that knockdown or loss of osa expression leads to significantly better eclosion of flies at 5% O~2~, indicating that osa is a repressor of genes that are important in hypoxia tolerance. Similarly, we found that an *in vivo* loss of *[sec8](http://flybase.org/reports/FBgn0262603.html)* and *[tna](http://flybase.org/reports/FBgn0026160.html)* function gives a survival advantage for eclosion in 5% O~2~. In contrast, an upregulation of the *[lqf](http://flybase.org/reports/FBgn0028582.html)* gene (F1-UASlqfXdagal4) significantly increases (98% eclosion compared with controls with eclosion rate of 7%) the eclosion rate of flies under hypoxia. Knockdown of *[lqf](http://flybase.org/reports/FBgn0028582.html)* (in mutant stocks lqfAR1, FDDR9, and F1-TRIP RNAiXda-gal4) tremendously reduced eclosion rates ([Figure 4](#fig4){ref-type="fig"}). This is very intriguing as *[lqf](http://flybase.org/reports/FBgn0028582.html)* is a Notch regulator, and we have previously shown the importance of Notch in hypoxia adaption in flies ([@bib62]).

![Gene expression in P-element lines. Real-time PCR analysis of P-element lines in normoxia and hypoxia. Means are statistically significant when *P* \< 0.05 (unpaired *t*-test comparing P-element lines with yw control).](1169f3){#fig3}

![Effect of alterations of single genes on hypoxia tolerance phenotype. Percentage eclosion of flies in which single genes were overexpressed or knocked out based on the real time PCR analysis of P-element lines. Each bar represents the average of at least three tests for each line (starting with 100--150 eggs); error bars represent the standard error.](1169f4){#fig4}

Tissue-specific overexpression or knockdown of *osa* and *lqf* genes {#s13}
--------------------------------------------------------------------

To determine whether there is any tissue-specific effect of knockdown or overexpression in various tissues such as the central nervous system, we utilized progenies of crosses made with specific GAL4 drivers. We then subjected the F1 progeny of such crosses to 5% O~2~ and quantified eclosion rates. As depicted in [Figure 5](#fig5){ref-type="fig"}, our data show that the specific knockdown of osa in the nervous system (elav-gal4) and mushroom body (MB) of the brain has an opposite effect on eclosion, as compared with increasing its expression ubiquitously (*i.e.* its knockdown in these tissues decreased eclosion rates) ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). This suggests that osa has a specific role in the central nervous system and that under hypoxia its loss of function decreases eclosion rates. Knockdown of *[osa](http://flybase.org/reports/FBgn0261885.html)* using the muscle-specific driver shows a similar phenotype of strong eclosion rate (90%) as ubiquitous expression ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"})

![Effect of tissue-specific overexpression of *osa*. *Osa* was upregulated in specific tissues using Gal4 drivers: (elav-gal4) nervous system, (c736) mushroom body of the brain, and (P{GawB}DJ667) muscle driver. The figure shows percentage eclosion of F1 progeny of the crosses. Each bar represents the average of at least three tests for each line (starting with 100--150 eggs); error bars represent the standard error.](1169f5){#fig5}

[Figure 6](#fig6){ref-type="fig"} shows data related to the *[lqf](http://flybase.org/reports/FBgn0028582.html)* gene. We have observed that upregulation of *[lqf](http://flybase.org/reports/FBgn0028582.html)* in glial cells leads to a significantly higher eclosion (93%, *P* \< 0.001). Furthermore, specific upregulation of *[lqf](http://flybase.org/reports/FBgn0028582.html)* in larval hemocytes increased eclosion (99%, *P* \< 0.001 *vs.* controls), and its knockdown had an opposite effect. Under 5% O~2~, knockdown of *[lqf](http://flybase.org/reports/FBgn0028582.html)* specifically in the muscles tremendously reduces eclosion rates. This may be linked to the abnormalities in wings and legs caused by loss of *[lqf](http://flybase.org/reports/FBgn0028582.html)* expression ([@bib8]), but we do not observe any significant lowering of eclosion rates under normoxia. This suggests that under hypoxia, the knockdown of *[lqf](http://flybase.org/reports/FBgn0028582.html)* in muscles has a significant impact on development.

![Effect of tissue-specific overexpression of lqf. lqf was upregulated in specific tissues using Gal4 drivers: (Eaat1) glial cells, (Hml-Gal4) larval hemocytes, and (P{GawB}DJ667) muscle driver. The figure shows percentage eclosion of F1 progeny of the crosses. Each bar represents the average of at least three tests for each line (starting with 100--150 eggs); error bars represent the standard error.](1169f6){#fig6}

Discussion {#s14}
==========

In the present study, we used a genome-wide P-SUP transposable element screen for hypoxia tolerance during all developmental stages in flies, starting from embryos at 5% O~2~. Out of 1870 genes screened, 44 genes showed strong hypoxia tolerance phenotype. This is intriguing because this is a relatively small number of genes that show a relation to hypoxia, indicating that there is some specificity between phenotype and genotype. This phenotype of hypoxia tolerance of these P-element lines was strong as they did not only show increased eclosion rate but also the number of flies that survived after eclosion was impressive compared with the wild-type flies. This result indicates that these candidate genes not only help in hypoxia tolerance across development but also in the adult after eclosion. We have examined the role of *[sec8](http://flybase.org/reports/FBgn0262603.html)*, *[osa](http://flybase.org/reports/FBgn0261885.html)*, *[tna](http://flybase.org/reports/FBgn0026160.html)*, and *[lqf](http://flybase.org/reports/FBgn0028582.html)* genes in hypoxia tolerance *in vivo*. These genes have varied molecular and biological functions but have not been previously studied in the context of survival in hypoxia. For instance, sec8 is a part of an evolutionarily conserved eight-subunit protein complex that is required for tethering exocytic carriers to target membranes in eukaryotic cells ([@bib39]). The liquid facets locus (*[lqf](http://flybase.org/reports/FBgn0028582.html)*) encodes epsin, a vertebrate protein associated with the clathrin endocytosis complex ([@bib8]). Recent studies support the view that many proteins governing membrane sorting during endocytosis participate also in nuclear signaling and transcriptional regulation, mostly by modulating the activity of various nuclear factors ([@bib41]). A number of these proteins are implicated in the regulation of cell proliferation and tumorigenesis ([@bib41]). In addition, besides endocytosis, sec8 is also involved in the regulation of synaptic microtubule formation and glutamate receptor trafficking ([@bib30]). Hence, these genes through their endocytic, neuronal, or transcriptional regulatory function significantly help in hypoxia tolerance.

*Osa* gene may also be acting as a transcriptional regulator. Indeed it is genetically linked to three other genes found in our present screen (*i.e. CycE*, *[Alh](http://flybase.org/reports/FBgn0261238.html)*, and *[tna](http://flybase.org/reports/FBgn0026160.html)*) ([@bib4]; [@bib18]). Recent studies have suggested an intriguing role for osa, which is to establish a chromatin environment in the regulatory regions of EGFR as well as WNT target genes, making them available for both activators and repressors and facilitating transcription in response to signaling ([@bib11]; [@bib50]). Osa-containing Brahma chromatin remodeling complexes are required for the repression of wingless target genes ([@bib12]; [@bib11]; [@bib53]). This osa-mediated repression acts on Groucho/Pangolin complex and specific downstream genes, such as Dpp, nubbin, and ubx of the Wg pathway ([@bib12]; [@bib11]; [@bib31]; [@bib55]). It is also noteworthy that osa showed tissue specificity, as its effect in the nervous system is opposite to that when it is expressed ubiquitously. A previous study has shown that *[osa](http://flybase.org/reports/FBgn0261885.html)* can negatively regulate proneuronal development through *[pannier](http://flybase.org/reports/FBgn0003117.html)* and *chip* genes through chromatin remodeling ([@bib20]). Hence, we can infer that it can act both as a positive and negative regulator of transcription, depending on its location and physiological function.

In previous studies in our laboratory, we have shown an effect of Notch on survival and adaptation of flies selected over generations under hypoxia ([@bib16]; [@bib17]; [@bib60]). Interestingly, in this study, we also find genes linked to Notch pathway as shown in [Table 2](#t2){ref-type="table"}. This is remarkable as there is no *a priori* reason for the screen to be baised to one pathway or another. Besides, in our current study no selection or adaptation to long-term hypoxia has been utilized. Nevertheless, a link to the Notch pathway for hypoxia tolerance during one generation is very interesting and would indicate that the Notch pathway is not only important for hypoxia survival in long-term (transgenerational) conditions but also in shorter-term hypoxia, including during development.

It is known that *[osa](http://flybase.org/reports/FBgn0261885.html)* and *[lqf](http://flybase.org/reports/FBgn0028582.html)* are strongly linked to the Notch pathway ([@bib2]; [@bib24]; [@bib54]; [@bib59]). In fact, lqf (ortholog of Mammalian Epsin) is a Notch regulator through Delta ([@bib38]). Epsin modulates Notch pathway activity in *Drosophila* and *C. elegans* ([@bib51]). It interacts with the Notch pathway during multiple Notch-dependant events in *Drosophila* ([@bib51]). Ligands of the Delta and Serrate must normally be endocytosed in signal-sending cells to activate Notch ([@bib38]; [@bib57]). It has been shown that only those molecules of Ser and Dl that are targeted by ubiquitination to enter the Epsin (vertebrate lqf)-dependent pathway have the capacity to activate Notch ([@bib52]; [@bib57]). Genetic studies have shown that the BRM complex (composed of brm, osa, and moira) shows a close functional connection with Notch signaling ([@bib2]). Hence, these genes could be functioning through the Notch signaling pathway to provide strong hypoxia tolerance. For example, osa is known to affect wing tissue, independent of its effect on the Wnt pathway. This might be related to Notch signaling in these cells as osa is also required to promote Dl (Notch ligand) expression in vein territories ([@bib50]). In addition, through its chromatin-remodeling activity, osa is known to regulate the cell cycle by coordinating cell-cycle progression through downstream genes, such as CycE interaction or string/cdc25 expression, in normal *vs.* cancer cells ([@bib4]; [@bib7]; [@bib34]). This cell-cycle arrest of cells requires the function of several signaling pathways: Wg, Egfr, and Notch as well as chromatin-remodeling controlling cell proliferation through the Notch pathway. Indeed, in our screen we found that P-element lines affecting CycE as well as Alh (polycomb gene controlling chromatin-structure) also had strong eclosion under hypoxia. This might be linked to Osa-CycE interaction or Osa-Alh chromatin modeling mediated by Notch regulation ([@bib44]). To study the effect of CycE overexpression in proliferation of bristle lineage in *Drosophila*, [@bib47] have shown that Notch acts as a repressor, whereas in Scrib mutants, Notch aids cooperatively in cell proliferation and survival with the Scrib gene ([@bib6]). The Notch signaling pathway and its interaction with ATG1 may be related to the function of Notch in macroautophagy during fly metamorphosis ([@bib26]). In a recent study, it has been shown that in *Drosophila* crystal cells, HIF1α/sima activates Notch receptor signaling, which promotes hemocyte survival during both normal hematopoietic development and hypoxic stress ([@bib36]). Hypoxia-inducible factor is considered to be one of the primary regulatory pathways involved in hypoxia tolerance ([@bib56]). Our screen included HIF1α/sima P-element line, and we found that the loss of sima in the P-element line showed similar phenotype of eclosion under hypoxia as controls. This is consistent with the previous study that showed that sima loss of function affects development under hypoxia ([@bib9]). As our screen is based on the phenotype of hypoxia tolerance, it is reassuring to see that the sima mutant did affect hypoxia tolerance and had low eclosion rates (less than 70%). This explains why we could not detect the role of HIF1α/sima, which is a major hypoxia-sensitive pathway, in our study. We also discovered that that hypoxia tolerance is polygenic as other pathways, such as Wnt, JNK, or Hedgehog, were linked to the candidate genes and played a role in hypoxia tolerance ([Table 2](#t2){ref-type="table"}). Our future goal is to study the mechanism(s) of hypoxia tolerance as mediated by these genes through genetic epistasis or interaction studies.

Other possibilities may also regulate the interplay of Osa and Wg signaling, such as mutual transcriptional regulation of common target genes ([@bib4]). In vertebrates, direct transcriptional regulation of cyclins by SWI/SNF complex (Osa mammalian ortholog) components has been implicated, and mammalian BRG1 (Osa-Brm complex) and β-catenin (the vertebrate ortholog of Armadillo) interact with each other to activate Wnt target genes ([@bib4]). Similarly, other mechanism(s) may be responsible for our observed hypoxia-tolerant phenotype. Our observation of the specific role of lqf in larval hemocytes in eclosion under hypoxia may be related to its autophagic function ([@bib13]). During the larval stage, hemocytes play an important role in adult and pupae structural remodeling involving both their phagocytotic (apoptotic cells) as well as their immune function ([@bib22]). Furthermore, in our screen, we found the tumor suppressor gene, lethal(3)malignant, which is required for the differentiation of hemocytes ([@bib27]). The P-element line in which this gene was upregulated showed strong eclosion under hypoxia, which reinforces the role of specific genes affecting hemocyte functions and thereby altering hypoxia tolerance ([@bib3]).

In summary, the P-element screen is a distinct method for identifying genes that lead to hypoxia tolerance in *Drosophila*. Indeed, by screening 2187 lines, we identified 44 strong hypoxia-tolerant lines (44 genes). The genes found in our screen not only play a role in hypoxia tolerance during development but also help in adult survival one week post eclosion. Of interest, we found that among the 44 lines that seemed hypoxia tolerant, a few genes (*[Drp1](http://flybase.org/reports/FBgn0026479.html)*,*[CG10700](http://flybase.org/reports/FBgn0032754.html)*, *CG30169*, *[l(3)mbn](http://flybase.org/reports/FBgn0002440.html)*, *[CG5235](http://flybase.org/reports/FBgn0036565.html)*, *[polo](http://flybase.org/reports/FBgn0003124.html)*, *[lqf](http://flybase.org/reports/FBgn0028582.html)*, *[CG6028](http://flybase.org/reports/FBgn0038924.html)*, *[sec8](http://flybase.org/reports/FBgn0262603.html)*, *[Cyclin E](http://flybase.org/reports/FBgn0010382.html)*, *[Atg1](http://flybase.org/reports/FBgn0260945.html)*, *[mRpS18B](http://flybase.org/reports/FBgn0032849.html)*, and *[ci](http://flybase.org/reports/FBgn0004859.html)*) were similar to those in our previous work on the hypoxia-adapted adult flies as well on the adapted *Drosophila* larvae ([@bib60], [@bib61]). This clearly reinforces the potential role of such genes in hypoxia tolerance. Furthermore, in this screen, for the first time we have discovered the distinct role of *[osa](http://flybase.org/reports/FBgn0261885.html)* and *[lqf](http://flybase.org/reports/FBgn0028582.html)* genes in hypoxia tolerance by over expressing or knocking down these genes *in vivo* ubiquitously or in specific tissues in *Drosophila*.
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